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At present probably the most popular 
and effective method to alleviate the 
withdrawal symptoms in narcotic addicts 
is the substitution of the stronger narcotics 
by methadone which because of its milder 
addictiveness can be more easily and 
rapidly withdrawn (Weiland and Cham-
bers, 1970). However, methadone itself 
is an addictive drug, its abuse liability 
being enhanced by the fact that it can 
also be used by injection and its compara-
tively low cost. Further, since it is no 
longer available in the Indian market a 
search must be made for a safe and effec-
tive substitute. There are two drugs 
that hold promise in this regard. 
Fraser and Isbell (1961) studied the 
addiction liability of diphenoxylate, a 
congener of Pethidine. They concluded 
that its abuse liability was less than that 
of morphine and comparable to codeine. 
Subsequently, Goodman (1968) reported 
the use of diphenoxylate in withdrawal 
of twenty narcotic addicts using a total 
dose of 260 nig. over five and a hall days. 
He concluded that it resulted in allaying 
the usual severe symptoms of withdrawal 
but found it necessary to use barbiturate 
and phet othiazines or glutethimide to 
control the symptoms of anxiety in these 
subjects. More recently GJatt et al. 
(1970 J found the combination of Dipheno-
xylate with Heminevrin to be quite effec-
tive in the treatment of the withdrawal 
abstinence syndrome in a series of 88 
narcotic (including 70 heroin) addicts. 
The analgesic, propoxyphene napsy-
late has also been used in a manner 
similar to methadone in the detoxification 
or maintenance of narcotic addicts. 
Because of its higher toxicity and low 
potency, it is considered to have a lower 
abuse potential than other opiate sub-
stitutes. In the treatment of addicts, 
this drug has been administered in oral 
doses ranging from 400. mg. to 1600 mg. 
per day—the higher doses often producing 
untoward side-effects like convulsions, 
dysphoria and toxic psychosis Recently 
Jasinsky et al. (1977) carried out studies 
to assess the morphine—like activity of 
propoxyphene napsylate as well as the 
more potent propoxyphene hydrochloride. 
According to their assessments, propoxy-
phene hydrocloride was approximately 
l/24th as potent, and propoxyphene 
napsylafe l/49th as potent as morphine 
in suppressing the abstinence synd'ome. 
In another paper, Tennant et al (1977) 
have also reported on the use of propoxy-
phene napsylate in daily dose of 1000, 
1000, 800. 500, 300, and 0 mg on con-
secutive days in the detoxification of 
narcotic (heroin) addicts under double-
blind conditions using placebo in iden-
tical capsules, and fjund good results 
and patient acceptance similar to that 
of methadone. 
1. Professor and Head 
2. Assistant Professor 
3. P.G. Student 
Department of Psychiatry, Government Medical College, Patiala. 344  GUKMEET SINGH etai 
In view of these reports it was con-
sidered worthwhile to assess the value of 
these two drugs in the treatment of with-
drawal symptoms in opium addicts in a 
con troll* d double-blir d study. 
MATERIAL AND METHOD 
One hundred and five consecutive 
patients with a diagnosis of opium addic-
tion who were admitted to the P.-ychiatry 
Ward of Rajendra Hospital, Patiala 
during the period 1980, 1981 and 1982 
for detoxification were taken up for the 
study. The patients with multiple addic-
tions or other gross psychiatric illnesses 
were excluded. After taking a detailed 
psychiatric history and medical examina-
tion, their present level of opium or 
narcotic intake was calculated in terms of 
Morphine. The study was conducted in 
two phases. In the first phase, with-
drawal was undertaken using the low 
dose regimen and in the second phase 
using the high dose regimen. In each 
phase of the sudy, subjects were randomly 
allocated to two treatment groups A and B. 
Group A receiving Diphenoxylate and 
Group B receiving Dexttopropoxyphene. 
The total daily dose to be administered, of 
either experimental drug, was calculated 
for each patient according to the present 
level of daily Morphine consumption e.g. 
in low dose regimen, the patients consum-
ing upto 250 mg of morphine daily were 
given 20 mg of Diphenoxylate if in 
group A or 400 mg. of Propoxyphene 
Napsylate if in Group B; those consuming 
between 250 to 500 mg. received 30 mg. 
of diphenoxylate or 600 mg of propoxy-
phene and those consuming more than 
500 mg. received 40 mg of diphenoxylate 
or 800 mg. of propoxyphene. In the 
high dose regimen the respective daily 
doses were doubled i.e. the do<e of 
diphenoxylate was between 40 to 80 mg. 
and of propoxyphene between 800 to 
1600 mg. daily in divided doses. The 
drrgs were administered by nurses on 
double blind basis in identical capsules— 
each capsule containing either 5 mg. of 
diphenoxylate or 100 mg. of propoxy-
phene. No other medicines wete given 
except mild hypnotics (for example 
Diazepam or Nitrazepam) at bed time. 
The procedure adopted for with-
drawal was the same as reported earlier 
by Singh and Lai (1975-76) in which 
the blocking dose of the drugs was 
adjusted upward or downward in first 
48 hours but thereafter maintained at the 
same level, for ten days and then sud-
denly withdrawn on 11th day to be 
replaced by the same number of identical 
looking placebos. In a few cases the 
initial calculated dose had to be adjusted 
because of the fact that the patient did 
not give an accurate estimate of amount 
of narcotic being consumed by him or 
because of varying potency of the opium 
available in the market. The patients 
were observed on placebos for three days 
and for next two days without the 
placebo. All the patients were assessed 
daily for presence of any abstinence 
symptom which were duly recorded in 
their case-sheets. As 15 patients out of 
105 (14%) dropped out during the course 
of study or attempted to smuggle in drugs 
clandestinely or were suspected to be 
taking narcotics during the treatment 
period and hence were removed from the 
study. Thus this report is based on an 
analysis of 90 patients who completed 
the full 15 days treatment programme. 
RESULT AND DISCUSSION 
As is evident from Table I all the 
patients in the present sudy were males 
between the age of 20 years to 58 years 
with a mean of 33.4 years. A vast majo-
rity were married and farmers or farm 
labourers. Interestingly there were more 
literates i.e. primary or upto matric edu-
cated in contrast to illiterates as expected DOUBLE BLrND STUDY OF OPIUM ADDICTS 
TABLE I—Demographic Characteristics of Total Sample 
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Age 
Marital Status 
Occupation 
Religion 
Education 
Range 
Mean 
Married 
Unmarried 
Divorced 
Farmers/Farm-Labourers 
Drivers 
Tech. 
Business 
Student 
Sikh 
Hindu 
Muslim 
Illiterate 
Primary 
Matric 
Above Matric 
Group A 
(Diphenoxylate) 
(N = 46) 
22-
32.9 
36 
8 
2 
36 
2 
4 
2 
2 
36 
8 
2 
12 
18 
12 
4 
•58 years 
years 
Group B 
(Dextropropoxyphene) 
(N=44) 
20—55 year* 
33.8 years 
44 
0 
0 
30 
4 
4 
4 
2 
34 
10 
0 
20 
12 
6 
6 
from the population norms for this com-
munity. Table II shows the type and 
amount of narcotic drugs used by the 
subjects. Thus in respect of all major 
demographic variables and the type and 
amount of narcotic drugs used in the two 
experimental groups were very similar. 
TABLE II—Amount of daily opiate consump-
tion of total sample 
Table III and IV pertain to findings 
in the low dose treatment group. Table 
III shows that the stabilising daily dose 
of diphenoxylate, ranging between 20 to 
40 mg. with a mean of 31.6 mg. and that 
of dextropropoxyphene was from 400 to 
800 mg. with a mean of 709.1 mg. Table 
IV shows the withdrawal symptoms repor-
ted during the treatment with a low dose 
regimen. Although practically all the 
Oral Opium Range 
Mean 
Intravenous-
Morphine Range 
Mean 
Group A 
1.5 to 10 gm. 
6gm. 
30 to 
300 mRm. 
190 mgm. 
Group B 
1.5 to 10 gm. 
4.8 gm. 
90 to 
500 mgm. 
295 mgm. 
TABLE III—Stabiliz 
{L.D. 
Range 
Mean 
Group A 
20 to 40 mg. 
31.6 mg. 
ing daily dose 
Group) 
Group B 
400 to 800 mg. 
709.1 mg. 346 GURMEET SINGH tt al. 
TABLE IV—Withdrawal Symptoms Reported During Treatment (L. D. Group) 
Group A Group B Significance 
(N=22) (N = 24) 
1. Body achts & pains 22 (100.0%) 24 (100.0%) N. S. 
Mild 14 (63.6%) 14 (58.3%) 
Severe 8 (36.4%) 10 (41.7%) 
2. Insomnia 16 (72.7%) 24 (100.0%) (p<0.05) 
3. Rhiuorrhoea/sneezing 14 (63.6%) 16 (66.6%) N. S. 
4. Diarrhoea 2 (9.1%) 10 (41.6%) (P<0-1) 
5. Nervousness/tremors 2 (9.1%) 4 (16.6%) N. S. 
6. Nausea/retching 0 (0.0%) 4 (16.6%) (p<0.1) 
7. Anorexia 4 (18.2%) 4 (16.6%) N. S. 
8. Lacrymation 4 (18.2%) 2 (3.3%) N. S. 
patients complained of body aches and 
pains these were mild in majority (60.9%) 
of cases with a mean duration of about 
3.7± 1.5 days. It is interesting that the 
sleep disturbance was not apparently 
related to the physical pains as Insomnia 
was complained of by only /2.7 per cent 
patients on Diphenoxylate as against the 
complaints of body aches by all the pati-
ents. There was no significant difference 
in relation to complaints of ihinorrhoea 
and sneezing, nervousness, tremois, 
lacrymation and .-jnorexia, between the 
two experimental drug groups except that 
Diphenoxylate was found better in con-
trolling diarriioea. There were no repor-
ted side effects with either of the drugs 
on this dose. 
Table V and VI pertain to findings 
in the high dose treatment group. Table 
V shows that the stabilising daily dose 
of Diphenoxylate was between 40 to 
60 mg with a mean of 56.6 mg. and that 
of Dextropropoxyphene was 800 to 1200 
mg. with a mean of 1120 mg. By and 
large, on the high dose schedule the 
period of narcotic withdrawal was charac-
terised by good cooperation and lack of 
daily petty complaints by the patients as 
witnessed in the low dose schedule. The 
complaint of bedyaches and pains were 
reported by only 28.3% of all patients 
and were mild in all cases not requiring 
any drug treatment apart from reassur-
ance. Complaints of insomnia were al?o 
markedly less with this high dose regimen 
(only 13.3% patients) and none of 
the patients reported diarrhoea, nausea, 
retching or anorexia with either ol the 
drugs. Complaints of Rhinorrhoea/sneez-
ing, nervousness were reduced with high 
dose of both the drugs. Only two side 
effects were encountered on thehigh dose 
trial viz.—constipation was repoi ted by 
one patient on Diphenoxylate while 
TABLE V—Stabilizing daily dose 
(H. o. Group) 
Range 
Mean 
Group A 
40-60 mg. 
56.6 mg. 
Group B 
GOO-1200 mg. 
1120 mg. DOUBLE BLIND STUDY OF OPIUM ADDICTS 
TABLE VI—Withdrawal Symptoms reported during treatment (JV. D. Group) 
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1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Body aches & Pains 
Mild 
Severe 
Insomnia 
Rhinorrhoea/sneezing 
Diarrhoea 
Nervousness/Tremors 
Nausea/retching 
Anorexia 
Lacrymation 
Side Effects reported 
Group A 
(N = 24) 
4 
4 
0 
4 
4 
0 
2 
0 
0 
2 
(16.6%) 
(16.6%) 
(16.6%) 
(16.6%) 
(0.0%) 
(»• %) 
(0.0%) 
(0.0%) 
(B.3%) 
Constipation 1 
8 
8 
0 
8 
4 
0 
0 
0 
0 
4 
Group B 
(N=2) 
(40.0%) 
(-10.0%) 
(10.0%) 
(20.(%) 
(0. %) 
(0-0%) 
(0-0%) 
(0.0%) 
(20.0%) 
Giddiiess2 
Significance 
N. S. 
N. S. 
N. S. 
N. S. 
N.S. 
X. S. 
2 persons on Propoxyphene complained 
of giddir.ess. The:e were both mild and 
did not necessitate discontinuation of the 
treatment. 
CONCLUSIONS 
The present study is an attempt to 
assess the efficacy and safety of use of 
Diphenoxylate and Dextropropoxyphene 
in the withdrawal of Narcotic addicts. 
In view of the reports of serious side 
effects like convulsions and toxic psychosis 
on high dose (i.e. upto 1610 mg. of 
Dextropropoxyphene) of these drugs by 
GlattWfl/. (1970) andJasinski^fl/. (1977) 
it was decided to carry out the study in 
two phases First one using dose ranging 
between 400 to 800 mg. and in the 
absence of any adverse effect we then 
went on to the second phase using dose 
range beiween 8C0 to 1600 mg. daily. 
The results of the present study demons-
trate that both Diphenoxylate and Pro-
poxyphene are both useful in alleviating 
the symptoms of opiate withdrawal quite 
effectively. With low dose regimen their 
less effectiveness is almost the same 
as of Methadone (Lai and Singh 1975-
76). Diphenoxylate appears to be 
slightly superior to Propoxyphene napsy-
late and being a cheap and easily avail-
able compound, with little abuse poten-
tial, is an ideal drug for detoxification of 
narcotic addicts in our Country. No 
adverse effects of any kind were reported 
on low dose schedule whereas on high 
dose regimen, giddiness and constipation 
were the only minor adverse effects 
reported. There was no case of any 
serious reaction like convulsion or toxic 
psychosis as reported earlier. This study 
again confirms the efficacy and safety of 
the technique of giving full blocking dose 
of the drug for 10 days followed by sudden 
withdrawal in the treatment of Opiate 
addicts. 
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